Thalidomide was initially marketed as a sedative and treatment for morning sickness in pregnant women during the late 1950s and early 1960s, but it led to severe birth defects, prompting stricter drug regulations worldwide. Today, thalidomide is used under strict controls for specific conditions like leprosy and multiple myeloma, showcasing its complex legacy in pharmacology and drug safety regulation.